跳至主要内容
临床试验/CTRI/2018/07/014933
CTRI/2018/07/014933尚未招募未知

â??Use of PET-CT with Gallium-68 labelled prostate Specific Membrane Antigen in the Diagnosis and Follow-up of patients with Prostate Cancerâ??

International Atomic Energy Agency0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with histologically proven diagnosis of PCa
  • 2. Patients with PCa that following RP or EBRT (with or without any adjuvant therapy) with serum levels of PSA between 0.2 ng/mL and 4 ng/mL, or PSA between 4-10 ng/mL with necessary negtive imaging investigation (BS, MR, CT).
  • 3. Gleason Score >= 7
  • 4. Age >= 35 years

排除标准

  • 1.Untreated patient with radical therapy (RP or EBRT)
  • 2.Previous cancer from other origin except non-melanoma skin cancer

研究者

相似试验